ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,170, issued on July 7, was assigned to RIBOMIC INC. (Tokyo).
"Aptamer for IL-21 and use thereof" was invented by Kazuteru Aoki (Tokyo) and Marie Mitsui (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an aptamer that binds to IL-21, an aptamer that binds to IL-21 and inhibits the binding of IL-21 and a receptor thereof, and an aptamer that binds to IL-21 and contains a nucleotide sequence represented by the formula (1): CGRYKACY wherein R is A or G, Y is C or U, and K is G or U."
The patent was filed on June 17, 2021, under Application No. 18/010,945.
*For further information, including images, charts and tables,...